Skip to main content

Advertisement

Log in

Burden of anxiety and depression among hospitalized patients with irritable bowel syndrome: a nationwide analysis

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Background and aim

Irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder that affects patients both physically and mentally. Our study aimed to investigate the burden of psychiatric disorders in IBS patients.

Methods

We conducted a retrospective analysis of the National inpatient sample (NIS) from 2016 to 2019. We recruited patients admitted with a diagnosis of IBS and determined the prevalence of anxiety, depression, and suicide attempt/ideation.

Results

We found a total of 1,256,325 hospitalizations with a diagnosis of IBS. Among them, 478,515 (38.1%) had anxiety and 344,165 (27.4%) had depression. The prevalence of psychiatric disorders including anxiety (38.1% vs. 15.1%), depression (38.1% vs. 15.1%), bipolar disorder (5.22% vs. 2.38%), suicidal attempt/Ideation (3.22% vs. 2.38%), and eating disorder (0.32% vs. 0.08%) was significantly higher in IBS patient population when compared to general adult population (p < 0.001). Patients with IBS had greater odds of anxiety (AOR 2.88, 95% CI 2.85–2.91, P < 0.001), depression (AOR 2.16, 95% CI 2.14–2.19, P < 0.001) and suicidal attempt/ideation (AOR 1.94, 95% CI 1.88–2.00, P < 0.001) in comparison to general population. IBS subtypes including diarrhea-predominant, constipation-predominant and mixed type were independently associated with increased odds of anxiety, depression, and suicide attempt/ideation. Patients with IBS and a co-diagnosis of anxiety or depression had increased mean length of hospital stay by 0.48 (95% CI 0.43–0.52, P < 0.001) and 0.52 (95% CI 0.06–0.97, P < 0.03) days, respectively.

Conclusion

The presence of IBS is associated with an increased associated prevalence of psychiatric disorders such as anxiety, depression, and suicide attempt/ideation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The analysis is based on the National Inpatient sample, which is a publicly available database maintained by the Agency of Healthcare cost and utilization project. Data can be shared on request.

References

  1. Chey WD, Kurlander J, Eswaran S (2015) Irritable bowel syndrome: a clinical review. JAMA 313(9):949–958

    Article  CAS  PubMed  Google Scholar 

  2. Lovell RM, AC (2012) Ford, Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 10(7):712–721e4

  3. Canavan C, West J, Card T (2014) Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 40(9):1023–1034

    Article  CAS  PubMed  Google Scholar 

  4. Corsetti M, Whorwell P (2017) The global impact of IBS: time to think about IBS-specific models of care? Therap Adv Gastroenterol 10(9):727–736

    Article  PubMed  PubMed Central  Google Scholar 

  5. Hulisz D (2004) The burden of illness of irritable bowel syndrome: current challenges and hope for the future. J Manag Care Pharm 10(4):299–309

    PubMed  Google Scholar 

  6. Mental Health Information Health Tpoics (2021) The national Institute of Mental health: Bethesda, MD

  7. Tarar ZI et al (2022) Burden of depression and anxiety among patients with inflammatory bowel disease: results of a nationwide analysis. Int J Colorectal Dis 37(2):313–321

    Article  PubMed  Google Scholar 

  8. Farzaneh N et al (2012) Evaluation of psychological aspects among subtypes of irritable bowel syndrome. Indian J Psychol Med 34(2):144–148

    Article  PubMed  PubMed Central  Google Scholar 

  9. Hausteiner-Wiehle C, Henningsen P (2014) Irritable bowel syndrome: relations with functional, mental, and somatoform disorders. World J Gastroenterol 20(20):6024–6030

    Article  PubMed  PubMed Central  Google Scholar 

  10. Zhang QE et al (2018) Depressive symptoms in patients with irritable bowel syndrome: a meta-analysis of comparative studies. Int J Biol Sci 14(11):1504–1512

    Article  PubMed  PubMed Central  Google Scholar 

  11. Twenge JM et al (2019) Age, period, and cohort trends in mood disorder indicators and suicide-related outcomes in a nationally representative dataset, 2005–2017. J Abnorm Psychol 128(3):185–199

    Article  PubMed  Google Scholar 

  12. Eaton NR et al (2012) An invariant dimensional liability model of gender differences in mental disorder prevalence: evidence from a national sample. J Abnorm Psychol 121(1):282–288

    Article  PubMed  Google Scholar 

  13. Kopczynska M et al (2018) Quality of life and depression in patients with irritable bowel syndrome. Prz Gastroenterol 13(2):102–108

    PubMed  PubMed Central  Google Scholar 

  14. Gralnek IM et al (2004) Racial differences in the impact of irritable bowel syndrome on health-related quality of life. J Clin Gastroenterol 38(9):782–789

    Article  PubMed  Google Scholar 

  15. El-Serag HB, Olden K, Bjorkman D (2002) Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 16(6):1171–1185

    Article  CAS  PubMed  Google Scholar 

  16. Frank L et al (2002) Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther 24(4):675–89 Discussion 674

  17. Nilsson D, Ohlsson B (2021) Gastrointestinal symptoms and irritable bowel syndrome are associated with female sex and smoking in the general population and with unemployment in men. Front Med (Lausanne) 8:646658

    Article  PubMed  Google Scholar 

  18. Pal A, Balhara YP (2016) A review of impact of tobacco use on patients with co-occurring psychiatric disorders. Tob Use Insights 9:7–12

    Article  PubMed  PubMed Central  Google Scholar 

  19. Gritz ER et al (1988) The effect of nicotine on the delay of gastric emptying. Aliment Pharmacol Ther 2(2):173–178

    Article  CAS  PubMed  Google Scholar 

  20. Scott AM et al (1992) Cigarette smoking and nicotine delay postprandial mouth-cecum transit time. Dig Dis Sci 37(10):1544–1547

    Article  CAS  PubMed  Google Scholar 

  21. Miller G et al (1989) Smoking delays gastric emptying of solids. Gut 30(1):50–53

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Meier R et al (1995) Influence of age, gender, hormonal status and smoking habits on colonic transit time. Neurogastroenterol Motil 7(4):235–238

    Article  CAS  PubMed  Google Scholar 

  23. Shah A et al (2020) Small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis of case-control studies. Am J Gastroenterol 115(2):190–201

    Article  PubMed  Google Scholar 

  24. Bynum TE et al (1972) Inhibition of pancreatic secretion in man by cigarette smoking. Gut 13(5):361–365

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Creed F (2019) Review article: the incidence and risk factors for irritable bowel syndrome in population-based studies. Aliment Pharmacol Ther 50(5):507–516

    Article  PubMed  Google Scholar 

  26. Sirri L, Grandi S, Tossani E (2017) Smoking in irritable bowel syndrome: a systematic review. J Dual Diagn 13(3):184–200

    Article  PubMed  Google Scholar 

  27. Midenfjord I et al (2019) Anxiety and depression in irritable bowel syndrome: exploring the interaction with other symptoms and pathophysiology using multivariate analyses. Neurogastroenterol Motil 31(8):e13619

    Article  PubMed  Google Scholar 

  28. Fadgyas-Stanculete M et al (2014) The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations. J Mol Psychiatry 2(1):4

    Article  PubMed  PubMed Central  Google Scholar 

  29. Weaver KR et al (2016) Neuroimaging the brain-gut axis in patients with irritable bowel syndrome. World J Gastrointest Pharmacol Ther 7(2):320–333

    Article  PubMed  PubMed Central  Google Scholar 

  30. Ford AC et al (2019) Effect of antidepressants and psychological therapies in irritable bowel syndrome: an updated systematic review and meta-analysis. Am J Gastroenterol 114(1):21–39

    Article  PubMed  Google Scholar 

  31. Laird KT et al (2017) Comparative efficacy of psychological therapies for improving mental health and daily functioning in irritable bowel syndrome: a systematic review and meta-analysis. Clin Psychol Rev 51:142–152

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

ZT, UF, FK, MG, YG: concept and design of the study, data collection, data analysis, interpretation of results, writing of the manuscript, and final revision. MT, SR, YZ, RS: interpretation of results and manuscript writing. All authors approved the final version of the manuscript.

Corresponding author

Correspondence to Zahid Ijaz Tarar.

Ethics declarations

Conflict of interest

The authors declare no competing of interests.

Ethical declaration.

All included authors declare no outside interests directly or significantly related to this paper.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tarar, Z.I., Farooq, U., Zafar, Y. et al. Burden of anxiety and depression among hospitalized patients with irritable bowel syndrome: a nationwide analysis. Ir J Med Sci 192, 2159–2166 (2023). https://doi.org/10.1007/s11845-022-03258-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-022-03258-6

Keywords

Navigation